FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2002197330> ?p ?o ?g. }

• W2002197330 endingPage "535" @default.
• W2002197330 startingPage "529" @default.
• W2002197330 abstract "Current treatment options for cGVHD are limited. Mast cells (MC) and fibroblasts have been shown to play a role in the murine model of cGVHD. Ketotifen is an anti-H-1 antihistamine with MC-stabilizing properties. We therefore treated eight patients with cGVHD with ketotifen (6 micrograms/day for 3 months). Three additional age- and sex-matched cGVHD patients served as controls. MC count and activation state in cGVHD skin biopsies and the in vitro effect of peripheral blood mononuclear cell (PBMC) supernatants on (i) histamine release by MC; (ii) 3T3-fibroblast proliferation; and (iii) prostaglandin E2 (PGE2) production, were evaluated. Ketotifen therapy resulted in clinical improvement in 4/8 patients, stabilization of the disease in 2/8, while in 2/8 patients the cGVHD progressed and they died of bacterial sepsis. Side effects were minimal. In the skin biopsies the number of MC was found to be 0.58 +/- 0.17 (n = 8) (field x 400) and the MC looked degranulated (toluidine blue staining). Following ketotifen therapy MC number was increased to 1.2 +/- 0.28 (n = 8) (P < 0.05). PBMC supernatants of cGVHD patients stimulated histamine release from cultured rat MC (n = 8) (2.7 +/- 0.5 micrograms/ml; normal values are 2.1 +/- 0.4 micrograms/ml, n = 5). Ketotifen therapy reduced the histamine release level to the normal range (2.0 +/- 0.5 micrograms/ml, P < 0.05) (n = 8). Ketotifen therapy had no significant effect on: (i) 3T3 fibroblast proliferation which was suppressed by cGVHD PBMC supernatants; (ii) the elevated PGE2 production which we observed when fibroblasts were incubated with the PBMC supernatants. These results indicate that ketotifen may play a therapeutic role in cGVHD." @default.
• W2002197330 created "2016-06-24" @default.
• W2002197330 creator A5022151510 @default.
• W2002197330 creator A5053467549 @default.
• W2002197330 creator A5058925624 @default.
• W2002197330 creator A5059915616 @default.
• W2002197330 date "1995-06-01" @default.
• W2002197330 modified "2023-09-27" @default.
• W2002197330 title "Ketotifen therapy in chronic graft-<i>versus</i>-host disease (cGVHD): effect on mast cells and fibroblasts" @default.
• W2002197330 cites W1490032473 @default.
• W2002197330 cites W1562876511 @default.
• W2002197330 cites W1597544321 @default.
• W2002197330 cites W1607481472 @default.
• W2002197330 cites W1667412464 @default.
• W2002197330 cites W1902951093 @default.
• W2002197330 cites W1970981066 @default.
• W2002197330 cites W19741579 @default.
• W2002197330 cites W1975747558 @default.
• W2002197330 cites W1978212259 @default.
• W2002197330 cites W1991594941 @default.
• W2002197330 cites W1999672999 @default.
• W2002197330 cites W2000922370 @default.
• W2002197330 cites W2023634686 @default.
• W2002197330 cites W2029836946 @default.
• W2002197330 cites W2031195889 @default.
• W2002197330 cites W2037693295 @default.
• W2002197330 cites W2038258464 @default.
• W2002197330 cites W2038614981 @default.
• W2002197330 cites W2049458831 @default.
• W2002197330 cites W2051395776 @default.
• W2002197330 cites W2058440903 @default.
• W2002197330 cites W2070814420 @default.
• W2002197330 cites W2076082405 @default.
• W2002197330 cites W2087457305 @default.
• W2002197330 cites W2089335263 @default.
• W2002197330 cites W2094292853 @default.
• W2002197330 cites W2115189929 @default.
• W2002197330 cites W2117581174 @default.
• W2002197330 cites W2150964219 @default.
• W2002197330 cites W2156183673 @default.
• W2002197330 cites W2339981418 @default.
• W2002197330 cites W2402330519 @default.
• W2002197330 cites W2402827994 @default.
• W2002197330 cites W2410619699 @default.
• W2002197330 cites W2416669293 @default.
• W2002197330 cites W2424812267 @default.
• W2002197330 cites W2465713240 @default.
• W2002197330 cites W2403720960 @default.
• W2002197330 doi "https://doi.org/10.1111/j.1365-2249.1995.tb03733.x" @default.
• W2002197330 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1534472" @default.
• W2002197330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7539727" @default.
• W2002197330 hasPublicationYear "1995" @default.
• W2002197330 type Work @default.
• W2002197330 sameAs 2002197330 @default.
• W2002197330 citedByCount "14" @default.
• W2002197330 countsByYear W20021973302014 @default.
• W2002197330 countsByYear W20021973302015 @default.
• W2002197330 countsByYear W20021973302020 @default.
• W2002197330 crossrefType "journal-article" @default.
• W2002197330 hasAuthorship W2002197330A5022151510 @default.
• W2002197330 hasAuthorship W2002197330A5053467549 @default.
• W2002197330 hasAuthorship W2002197330A5058925624 @default.
• W2002197330 hasAuthorship W2002197330A5059915616 @default.
• W2002197330 hasBestOaLocation W20021973301 @default.
• W2002197330 hasConcept C1122143 @default.
• W2002197330 hasConcept C126322002 @default.
• W2002197330 hasConcept C137061746 @default.
• W2002197330 hasConcept C202751555 @default.
• W2002197330 hasConcept C203014093 @default.
• W2002197330 hasConcept C2776042228 @default.
• W2002197330 hasConcept C2776880894 @default.
• W2002197330 hasConcept C2777956040 @default.
• W2002197330 hasConcept C2779726688 @default.
• W2002197330 hasConcept C2780381497 @default.
• W2002197330 hasConcept C2780571441 @default.
• W2002197330 hasConcept C55493867 @default.
• W2002197330 hasConcept C71924100 @default.
• W2002197330 hasConcept C86803240 @default.
• W2002197330 hasConcept C90924648 @default.
• W2002197330 hasConceptScore W2002197330C1122143 @default.
• W2002197330 hasConceptScore W2002197330C126322002 @default.
• W2002197330 hasConceptScore W2002197330C137061746 @default.
• W2002197330 hasConceptScore W2002197330C202751555 @default.
• W2002197330 hasConceptScore W2002197330C203014093 @default.
• W2002197330 hasConceptScore W2002197330C2776042228 @default.
• W2002197330 hasConceptScore W2002197330C2776880894 @default.
• W2002197330 hasConceptScore W2002197330C2777956040 @default.
• W2002197330 hasConceptScore W2002197330C2779726688 @default.
• W2002197330 hasConceptScore W2002197330C2780381497 @default.
• W2002197330 hasConceptScore W2002197330C2780571441 @default.
• W2002197330 hasConceptScore W2002197330C55493867 @default.
• W2002197330 hasConceptScore W2002197330C71924100 @default.
• W2002197330 hasConceptScore W2002197330C86803240 @default.
• W2002197330 hasConceptScore W2002197330C90924648 @default.
• W2002197330 hasIssue "3" @default.
• W2002197330 hasLocation W20021973301 @default.
• W2002197330 hasLocation W20021973302 @default.
• W2002197330 hasLocation W20021973303 @default.

• next